JP2021512852A5 - - Google Patents

Info

Publication number
JP2021512852A5
JP2021512852A5 JP2020538791A JP2020538791A JP2021512852A5 JP 2021512852 A5 JP2021512852 A5 JP 2021512852A5 JP 2020538791 A JP2020538791 A JP 2020538791A JP 2020538791 A JP2020538791 A JP 2020538791A JP 2021512852 A5 JP2021512852 A5 JP 2021512852A5
Authority
JP
Japan
Prior art keywords
article
coating according
compound
coating
steroids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020538791A
Other languages
English (en)
Japanese (ja)
Other versions
JP7502186B2 (ja
JP2021512852A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2019/050135 external-priority patent/WO2019148293A1/en
Publication of JP2021512852A publication Critical patent/JP2021512852A/ja
Publication of JP2021512852A5 publication Critical patent/JP2021512852A5/ja
Application granted granted Critical
Publication of JP7502186B2 publication Critical patent/JP7502186B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020538791A 2018-02-02 2019-02-01 ステロイド二量体を含むガラス製剤およびその使用 Active JP7502186B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862625460P 2018-02-02 2018-02-02
US62/625,460 2018-02-02
US201862627608P 2018-02-07 2018-02-07
US62/627,608 2018-02-07
US201862758234P 2018-11-09 2018-11-09
US62/758,234 2018-11-09
PCT/CA2019/050135 WO2019148293A1 (en) 2018-02-02 2019-02-01 Glass formulations comprising steroid dimers and uses thereof

Publications (3)

Publication Number Publication Date
JP2021512852A JP2021512852A (ja) 2021-05-20
JP2021512852A5 true JP2021512852A5 (cg-RX-API-DMAC7.html) 2022-01-31
JP7502186B2 JP7502186B2 (ja) 2024-06-18

Family

ID=67479137

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020538791A Active JP7502186B2 (ja) 2018-02-02 2019-02-01 ステロイド二量体を含むガラス製剤およびその使用

Country Status (9)

Country Link
US (9) US11612567B2 (cg-RX-API-DMAC7.html)
EP (1) EP3740494A4 (cg-RX-API-DMAC7.html)
JP (1) JP7502186B2 (cg-RX-API-DMAC7.html)
KR (1) KR102952719B1 (cg-RX-API-DMAC7.html)
CN (1) CN111971292B (cg-RX-API-DMAC7.html)
AU (1) AU2019214347B2 (cg-RX-API-DMAC7.html)
CA (1) CA3087898A1 (cg-RX-API-DMAC7.html)
MX (1) MX2020008017A (cg-RX-API-DMAC7.html)
WO (3) WO2019148294A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3740494A4 (en) 2018-02-02 2021-11-03 Ripple Therapeutics Corporation GLASS FORMULATIONS WITH STEROID DIMERS AND USES THEREOF
WO2020154815A1 (en) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
JP2022548464A (ja) * 2019-07-10 2022-11-21 リップル セラピューティクス コーポレーションズ 二量体ステロイドプロドラッグを含む表面コーティングおよび埋込み可能なデバイス、およびその使用
WO2021014217A1 (en) * 2019-07-25 2021-01-28 Ripple Therapeutics Corporation Articles comprising steroid dimers and their use in the delivery of therapeutic agents
US12509469B2 (en) 2019-08-07 2025-12-30 Ripple Therapeutics Corporation Compositions and methods for the treatment of pain and dependence disorders
CN111485325A (zh) * 2020-04-16 2020-08-04 青岛科技大学 一种耐高温的抗菌纳米纤维无纺布及其制备方法和用途
CA3176134A1 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
EP4108231A1 (en) 2021-06-25 2022-12-28 Johann-Wolfgang-Goethe-Universität Frankfurt am Main In-situ dissolving electrospun polymer fibers for ocular drug delivery
EP4426712A4 (en) * 2021-11-03 2026-04-08 Ripple Therapeutics Corp COMPOSITIONS SUITABLE FOR PROCESSING AND THEIR USE
US20260007686A1 (en) * 2022-07-12 2026-01-08 Ripple Therapeutics Corporation Compositions and methods for improving vision
AU2024238803A1 (en) * 2023-03-23 2025-10-09 Praesidia Biotherapeutics Inc. Prodrugs, prodrug compositions and related methods
TR2024002978A1 (tr) * 2024-03-12 2025-09-22 İstanbul Tekni̇k Üni̇versi̇tesi̇ Elektroeği̇rme yöntemi̇yle elde edi̇len ve i̇laç yüklü bi̇yopoli̇mer nanoli̇flerle kaplanan göz i̇mplanti üreti̇m yöntemi̇

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1058886A (en) 1910-04-13 1913-04-15 Alfred Mueller Firing mechanism for firearms.
FR7604M (cg-RX-API-DMAC7.html) 1968-04-22 1970-01-19
DE1768345B2 (de) 1968-05-03 1976-12-02 Hoechst Ag, 6000 Frankfurt Dimere steroid-21-alkylcarbonate und verfahren zu ihrer herstellung
US4024871A (en) 1975-07-23 1977-05-24 Ethicon, Inc. Antimicrobial sutures
US4532316A (en) 1984-05-29 1985-07-30 W. L. Gore & Assoc., Inc. Phase separating polyurethane prepolymers and elastomers prepared by reacting a polyol having a molecular weight of 600-3500 and isocyanate and a low molecular weight chain extender in which the ratios of reactants have a limited range
PL257230A1 (en) 1985-12-31 1988-03-03 Zaklad Polimerow Pan Novel segmented polymer and method of obtaining them
IL88003A (en) 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
US4916193A (en) 1987-12-17 1990-04-10 Allied-Signal Inc. Medical devices fabricated totally or in part from copolymers of recurring units derived from cyclic carbonates and lactides
US5250524A (en) * 1990-12-06 1993-10-05 Hoechst Aktiengesellschaft Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals
US5321099A (en) 1992-01-02 1994-06-14 The Dow Chemical Company Blends of semi-crystalline polyamides and polyesteramides
US5217493A (en) 1992-03-11 1993-06-08 Board Of Regents, The University Of Texas System Antibacterial coated medical implants
TW289020B (cg-RX-API-DMAC7.html) * 1993-05-08 1996-10-21 Hoechst Sktiengesellschaft
IT1270836B (it) 1993-10-27 1997-05-13 Archimica Spa Procedimento per la preparazione di rufloxacina e suoi sali
US6051576A (en) 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
PT740650E (pt) * 1994-01-28 2004-10-29 Univ Kentucky Res Found Co-farmacos como um metodo de administracao controlada de farmacos
SI0755386T1 (en) 1994-04-13 2002-10-31 Romark Laboratories, L.C. Benzamide derivative, compositions containing said derivative and use thereof
US5578621A (en) 1994-09-08 1996-11-26 Romark Lab Lc Benzamide derivatives
US5387598A (en) 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
US5965590A (en) 1994-09-08 1999-10-12 Romark Lab Lc Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US5859038A (en) 1994-09-08 1999-01-12 Romark Laboratories, L.C. Method for treatment of helicobacter pylori infections
US5856348A (en) 1994-09-08 1999-01-05 Romark Laboratories, L.C. Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
US5968961A (en) 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
MX9604483A (es) 1994-09-08 1998-02-28 Jean-Francois Rossignol Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
DE19521642C2 (de) 1995-06-14 2000-11-09 Aesculap Ag & Co Kg Implantat, seine Verwendung in der Chirurgie und Verfahren zu seiner Herstellung
WO1997006195A1 (en) 1995-08-03 1997-02-20 Santerre Paul J Fluoroligomer surface modifiers for polymers and articles made therefrom
EP0874643B1 (en) 1996-02-15 2001-11-21 J. Paul Santerre Bioresponsive pharmacologically-active polymers and articles made therefrom
KR0176334B1 (ko) 1996-08-19 1999-04-01 박원훈 내인체 감염성 삽입금속표면의 코팅방법 및 그 치료기술
US5728751A (en) 1996-11-25 1998-03-17 Meadox Medicals, Inc. Bonding bio-active materials to substrate surfaces
SI20149B (en) 1997-05-07 2001-08-31 Romark Lab Lc Pharmaceutical compositions of tizoxanide and nitazoxanide
US6153211A (en) 1997-07-18 2000-11-28 Infimed, Inc. Biodegradable macromers for the controlled release of biologically active substances
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US6468519B1 (en) 1997-09-10 2002-10-22 Rutgers, The State University Of New Jersey Polyanhydrides with biologically active degradation products
AU750424C (en) 1997-09-10 2003-05-15 Rutgers, The State University Of New Jersey Polyanhydrides with therapeutically useful degradation products
PT1019111E (pt) 1998-04-27 2002-10-31 Surmodics Inc Revestimento que liberta um agente bioactivo
WO2000010622A1 (en) 1998-08-20 2000-03-02 Cook Incorporated Coated implantable medical device
CA2377468C (en) 1999-07-27 2010-04-20 Phylos, Inc. Peptide acceptor ligation methods
CA2771263A1 (en) 2000-07-27 2002-02-07 Rutgers, The State University Therapeutic polyesters and polyamides
US6602915B2 (en) 2000-07-27 2003-08-05 Rutgers, The State University Of New Jersey Therapeutic azo-compounds for drug delivery
BR0209198A (pt) 2001-04-26 2004-06-08 Control Delivery Sys Inc Métodos de sìntese de compostos contendo fenol
CA2349989A1 (en) 2001-06-07 2002-12-07 Paul J. Santerre Bioactive surface modifiers for polymers and articles made therefrom
US9056048B2 (en) * 2001-08-16 2015-06-16 The Trustees Of The University Of Pennsylvania Synthesis and use of cationic steroids for anti-inflammatory drug therapy
US20030158598A1 (en) 2001-09-17 2003-08-21 Control Delivery Systems, Inc. System for sustained-release delivery of anti-inflammatory agents from a coated medical device
BR0212897A (pt) 2001-09-21 2004-08-24 Univ Tulane Conjugados de análogos de somatostatina ou bombesina diagnóstica ou terapêutica e usos dos mesmos
AUPR879601A0 (en) 2001-11-09 2001-12-06 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US20030118528A1 (en) * 2001-11-19 2003-06-26 Walters Kenneth A. Topical delivery of codrugs
US20050164994A1 (en) 2001-12-10 2005-07-28 Control Deliver Systems, Inc. Treatment of genitourinary tract disorders
WO2003061626A1 (en) * 2002-01-18 2003-07-31 Control Delivery Systems, Inc. Polymeric gel system for the controlled delivery of codrugs
EP1542664A4 (en) 2002-08-14 2008-04-16 Med College Georgia Res Inst METHOD AND COMPOSITIONS FOR TREATING MACULA AND RETINA DISEASES
TW200500067A (en) 2003-01-21 2005-01-01 Control Delivery Sys Inc Salts of codrugs and uses related thereto
US20050008695A1 (en) 2003-05-21 2005-01-13 Control Delivery Systems, Inc. Compositions and methods for delivering a biologically active agent
US7067504B2 (en) 2004-01-15 2006-06-27 Warner Chilcott Company, Inc. Di-steroidal prodrugs of ethinyl estradiol
CN1964749A (zh) 2004-04-06 2007-05-16 苏莫迪克斯公司 用于生物活性剂的涂料组合物
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
CA2571320C (en) 2004-05-14 2016-05-10 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
WO2005110485A1 (en) 2004-05-14 2005-11-24 Interface Biologics Inc. Polymeric coupling agents and pharmaceutically-active polymers made therefrom
EP2273989A4 (en) 2008-04-07 2013-05-01 Interface Biologics Inc COMBINATION THERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS
US8461171B2 (en) 2010-02-09 2013-06-11 QRxPharma Ltd. Hybrid opioid compounds and compositions
WO2011120044A1 (en) 2010-03-26 2011-09-29 Duke University Conjugated neuroactive steroid compositions and methods of use
US8968626B2 (en) 2011-01-31 2015-03-03 Arsenal Medical, Inc. Electrospinning process for manufacture of multi-layered structures
US8946254B2 (en) 2012-01-10 2015-02-03 Virginia Commonwealth University Bivalent ligands for the treatment of neurological disorders
WO2014138359A1 (en) 2013-03-08 2014-09-12 Allergan, Inc. Steroid antibiotic conjugates
EP2968698B1 (en) 2013-03-15 2018-01-10 Interface Biologics Inc. Coating for drug release
AU2015253417B2 (en) 2014-04-28 2020-02-20 Dimerx, Inc. Pharmaceutically active dimers linked through phenolic hydroxyl groups
WO2017083794A1 (en) 2015-11-12 2017-05-18 Board Of Regents Of The University Of Nebraska Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
EP3740494A4 (en) 2018-02-02 2021-11-03 Ripple Therapeutics Corporation GLASS FORMULATIONS WITH STEROID DIMERS AND USES THEREOF
WO2020154815A1 (en) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
JP2022548464A (ja) 2019-07-10 2022-11-21 リップル セラピューティクス コーポレーションズ 二量体ステロイドプロドラッグを含む表面コーティングおよび埋込み可能なデバイス、およびその使用
WO2021014217A1 (en) 2019-07-25 2021-01-28 Ripple Therapeutics Corporation Articles comprising steroid dimers and their use in the delivery of therapeutic agents

Similar Documents

Publication Publication Date Title
DE69232925T2 (de) Angiostatische steroide
CN111971292B (zh) 包含类固醇二聚体的玻璃制剂及其用途
PL207955B1 (pl) 17α-Alkilo-17ß-oksy-estratrieny, ich zastosowanie oraz preparaty farmaceutyczne je zawierające
JP2009538879A (ja) 後眼部の疾患治療用のステロイドプロドラッグの使用
JP2002520287A (ja) 黄斑変性における血管新生の予防的治療
JP2010511730A (ja) テストステロンおよびプロゲスターゲンを用いたドライアイのための処置
EP1755616A2 (en) Treatment of ophthalmic conditions with mineralcorticoids
JP2002539263A (ja) 徐放性副腎皮質ステロイドによる網膜症の治療方法または防止方法
WO2011009530A2 (de) 17-hydroxy-17-pentafluorethyl-estra-4,9 (10)-dien-11-acyloxyalkylenphenyl-derivate, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von krankheiten
JP2007535367A5 (cg-RX-API-DMAC7.html)
JP2015506983A5 (cg-RX-API-DMAC7.html)
US20070238714A1 (en) Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
JP2022548464A (ja) 二量体ステロイドプロドラッグを含む表面コーティングおよび埋込み可能なデバイス、およびその使用
EP2941437A1 (en) Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
JP2013523748A5 (cg-RX-API-DMAC7.html)
CN100431544C (zh) 用于治疗病理性眼血管生成的糖皮质激素制剂
CA2064478C (en) Ophthalmic composition
US20090029954A1 (en) Progesterone-receptor antagonist for use in brca alone or as combination with antiestrogen
US20080261929A1 (en) Combination of progesterone-receptor antagonist together with an aromatase inhibitor for use in brca mediated diseases
US20060094664A1 (en) Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation
US20250387410A1 (en) Treatment of anti-vegf refractory ophthalmic retinal eye conditions
CA2620346A1 (en) Control of induced elevated intraocular pressure
JP2025507416A5 (cg-RX-API-DMAC7.html)
EP1781301A2 (en) Angiostatic agents for controlling choroidal neovascularisation after ocular surgery or trauma
CN101094690A (zh) 用于治疗眼后节的组合物及方法